Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,583.16
    -1,431.08 (-2.86%)
     

  • CMC Crypto 200

    1,256.60
    -101.41 (-7.47%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

U.S. top court rejects GSK bid to throw out racketeering lawsuits

Reuters - UK Focus

WASHINGTON, June 6 (Reuters) - The U.S (Other OTC: UBGXF - news) . Supreme Court on Monday declined to hear GlaxoSmithKline Plc (Other OTC: GLAXF - news) 's bid to throw out lawsuits by union health and welfare funds that said the company's misrepresentation of heart-related risks of its diabetes medication Avandia caused them to pay too much for the drug for insured patients.

The court left in place an October 2015 ruling by the Philadelphia-based 3rd U.S. Circuit Court of Appeals against London-based GlaxoSmithKline that allowed the class action lawsuits to proceed. The suits were filed by three labor union funds that provide medical coverage, including the cost of prescription medications, to union members and their families. (Reporting by Lawrence Hurley; Editing by Will Dunham)